<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">EJC Suppl</journal-id><journal-id journal-id-type="iso-abbrev">EJC Suppl</journal-id><journal-title-group><journal-title>EJC Supplements</journal-title></journal-title-group><issn pub-type="ppub">1359-6349</issn><issn pub-type="epub">1878-1217</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26217137</article-id><article-id pub-id-type="pmc">4041307</article-id><article-id pub-id-type="publisher-id">S1359-6349(13)00040-2</article-id><article-id pub-id-type="doi">10.1016/j.ejcsup.2013.07.039</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Current role of human papillomavirus in head and neck oncology</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lassen</surname><given-names>Pernille</given-names></name><email>pernille@oncology.dk</email><xref rid="cor1" ref-type="corresp">&#x0204e;</xref></contrib></contrib-group><aff id="af005">Aarhus University Hospital, Department of Experimental Clinical Oncology, Aarhus C, Denmark</aff><author-notes><corresp id="cor1"><label>&#x0204e;</label>Tel.: +45 7846 2620; fax: +45 8619 7109. <email>pernille@oncology.dk</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>05</day><month>10</month><year>2013</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>9</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>05</day><month>10</month><year>2013</year></pub-date><volume>11</volume><issue>2</issue><fpage>260</fpage><lpage>261</lpage><permissions><copyright-statement>Copyright &#x000a9; 2013 ECCO - the European CanCer Organisation. All rights reserved.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Elsevier Ltd</copyright-holder><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).</license-p></license></permissions></article-meta></front><body><p>Tobacco and alcohol were, until recently, considered to be the major risk factors in carcinogenesis of head and neck cancer (HNSCC). However, during the past decade a causal association between infection with human papillomavirus (HPV) and HNSCC has been established <xref rid="b0005" ref-type="bibr">[1]</xref>, and this &#x02018;new&#x02019; aetiological factor has changed the conventional understanding of HNSCC because of the extensive influence of the virus on the epidemiology, clinical presentation and treatment outcome for patients with HNSCC.</p><p>Association with HPV is predominantly a matter of concern in tumours of the oropharynx, especially in tonsillar cancer <xref rid="b0010 b0015" ref-type="bibr">[2,3]</xref>, and a dramatic increase in the incidence of oropharyngeal cancer (OPC) has been reported in several Western countries over the past 30&#x000a0;years <xref rid="b0020 b0025 b0030 b0035 b0040" ref-type="bibr">[4&#x02013;8]</xref>. Based on the observations that, simultaneously, there has been an increase in the frequency of HPV-positivity among OPCs <xref rid="b0020 b0045" ref-type="bibr">[4,9]</xref>, infection with HPV seems to be the dominant cause of this development. Moreover, in the same time period a decrease in tobacco-smoking seems to be responsible for a reduction in the incidence of HNSCC outside the oropharynx <xref rid="b0030" ref-type="bibr">[6]</xref>, at least in Western countries. The natural history of oral HPV infection remains to be fully elucidated, and although the exact mechanism is not known, oral&#x02013;genital contact is assumed to be the primary mode by which HPV is transmitted to the oral mucosa, and several case&#x02013;control studies have shown an association between HPV-related HNSCC and sexual behaviour (reviewed by Gillison et al. <xref rid="b0015" ref-type="bibr">[3]</xref>). The optimal method for detecting HPV in tumours is controversial, and both in-situ hybridisation and the polymerase chain reaction (PCR) are commonly used; p16-immunohistochemistry has gained broad acceptance as a surrogate marker and is also widely used in the clinical setting <xref rid="b0050 b0055" ref-type="bibr">[10,11]</xref>.</p><p>HPV-related HNSCC constitutes a clinically distinct subgroup of cancers in terms of molecular biology, patient characteristics and sensitivity to treatment, and this on the whole differentiates it markedly from HPV-negative tumours. The molecular profile of HPV-related HNSCC is distinct, with P53 degradation, retinoblastoma RB pathway inactivation and p16 up-regulation. By contrast, HPV-negative tumours are characterised by TP53 mutation and down-regulation of p16 <xref rid="b0060 b0065" ref-type="bibr">[12,13]</xref>. Patients with HPV-related HNSCC tend to be younger, have less comorbidity and a better performance status <xref rid="b0070 b0075 b0080" ref-type="bibr">[14&#x02013;16]</xref>, and are less declined to be abusers of tobacco and alcohol <xref rid="b0030 b0075" ref-type="bibr">[6,15]</xref> compared with HPV-negative patients.</p><p>Tumour HPV status has a major impact on outcome for patients with HNSCC, and compared with HPV-negative patients, tumour-control and survival are highly significantly better for patients with HPV-positive tumours. This has been shown repeatedly in several clinical trials and with the use of a variety of different treatment schedules <xref rid="b0085 b0090 b0095 b0100 b0105 b0110" ref-type="bibr">[17&#x02013;22]</xref> and is believed to be caused in part by a higher sensitivity to radiotherapy of HPV-positive tumours, presumably because of the distinct molecular profile <xref rid="b0115" ref-type="bibr">[23]</xref>, combined with a better general health status in this group of patients. Smoking negatively affects survival in HNSCC, and the accumulated lifetime number of pack years independently impacts prognosis for both HPV-positive and -negative tumours <xref rid="b0105 b0120" ref-type="bibr">[21,24]</xref>; implementation of smoking history in the risk stratification of HNSCC is under consideration.</p><p>As a consequence of this profound impact of HPV in HNSCC, this &#x02018;new&#x02019; type of cancer has attracted a lot of attention, and separate therapeutic treatment strategies based on tumour HPV status are in the pipeline. In light of the enhanced sensitivity to treatment of HPV-related HNSCC, de-intensification of present treatment strategies in order to avoid excessive toxicity has been proposed for selected patients with minimal risk of distant metastasis <xref rid="b0125" ref-type="bibr">[25]</xref>. On the other hand, patients with HPV-negative tumours have a very poor prognosis, and efforts should be made to improve treatment efficacy and compliance in this group of patients.</p><sec id="s0005"><title>Conflict of interest statement</title><p>None declared.</p></sec></body><back><ref-list><title>References</title><ref id="b0005"><label>1</label><element-citation publication-type="journal" id="h0005"><person-group person-group-type="author"><name><surname>Gillison</surname><given-names>M.L.</given-names></name><name><surname>Koch</surname><given-names>W.M.</given-names></name><name><surname>Capone</surname><given-names>R.B.</given-names></name></person-group><article-title>Evidence for a causal association between human papillomavirus and a subset of head and neck cancers</article-title><source>J Natl Cancer Inst</source><volume>92</volume><year>2000</year><fpage>709</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">10793107</pub-id></element-citation></ref><ref id="b0010"><label>2</label><element-citation publication-type="journal" id="h0010"><person-group person-group-type="author"><name><surname>Sudhoff</surname><given-names>H.H.</given-names></name><name><surname>Schwarze</surname><given-names>H.P.</given-names></name><name><surname>Winder</surname><given-names>D.</given-names></name></person-group><article-title>Evidence for a causal association for HPV in head and neck cancers</article-title><source>Eur Arch Otorhinolaryngol</source><volume>268</volume><year>2011</year><fpage>1541</fpage><lpage>1547</lpage><pub-id pub-id-type="pmid">21792686</pub-id></element-citation></ref><ref id="b0015"><label>3</label><element-citation publication-type="journal" id="h0015"><person-group person-group-type="author"><name><surname>Gillison</surname><given-names>M.L.</given-names></name><name><surname>Alemany</surname><given-names>L.</given-names></name><name><surname>Snijders</surname><given-names>P.J.</given-names></name></person-group><article-title>Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis</article-title><source>Vaccine</source><volume>30</volume><issue>Suppl. 5</issue><year>2012</year><fpage>F34</fpage><lpage>F54</lpage><pub-id pub-id-type="pmid">23199965</pub-id></element-citation></ref><ref id="b0020"><label>4</label><element-citation publication-type="journal" id="h0020"><person-group person-group-type="author"><name><surname>Lassen</surname><given-names>P.</given-names></name></person-group><article-title>The role of human papillomavirus in head and neck cancer and the impact on radiotherapy outcome</article-title><source>Radiother Oncol</source><volume>95</volume><year>2010</year><fpage>371</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">20493569</pub-id></element-citation></ref><ref id="b0025"><label>5</label><element-citation publication-type="journal" id="h0025"><person-group person-group-type="author"><name><surname>Blomberg</surname><given-names>M.</given-names></name><name><surname>Nielsen</surname><given-names>A.</given-names></name><name><surname>Munk</surname><given-names>C.</given-names></name></person-group><article-title>Trends in head and neck cancer incidence in Denmark, 1978&#x02013;2007: focus on human papillomavirus associated sites</article-title><source>Int J Cancer</source><volume>129</volume><year>2011</year><fpage>733</fpage><lpage>741</lpage><pub-id pub-id-type="pmid">20878955</pub-id></element-citation></ref><ref id="b0030"><label>6</label><element-citation publication-type="journal" id="h0030"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>A.K.</given-names></name><name><surname>Engels</surname><given-names>E.A.</given-names></name><name><surname>Anderson</surname><given-names>W.F.</given-names></name></person-group><article-title>Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States</article-title><source>J Clin Oncol</source><volume>26</volume><year>2008</year><fpage>612</fpage><lpage>619</lpage><pub-id pub-id-type="pmid">18235120</pub-id></element-citation></ref><ref id="b0035"><label>7</label><element-citation publication-type="journal" id="h0035"><person-group person-group-type="author"><name><surname>Hammarstedt</surname><given-names>L.</given-names></name><name><surname>Dahlstrand</surname><given-names>H.</given-names></name><name><surname>Lindquist</surname><given-names>D.</given-names></name></person-group><article-title>The incidence of tonsillar cancer in Sweden is increasing</article-title><source>Acta Otolaryngol</source><volume>127</volume><year>2007</year><fpage>988</fpage><lpage>992</lpage><pub-id pub-id-type="pmid">17712680</pub-id></element-citation></ref><ref id="b0040"><label>8</label><element-citation publication-type="journal" id="h0040"><person-group person-group-type="author"><name><surname>Marur</surname><given-names>S.</given-names></name><name><surname>D&#x02019;Souza</surname><given-names>G.</given-names></name><name><surname>Westra</surname><given-names>W.H.</given-names></name></person-group><article-title>HPV-associated head and neck cancer: a virus-related cancer epidemic</article-title><source>Lancet Oncol</source><volume>11</volume><year>2010</year><fpage>781</fpage><lpage>789</lpage><pub-id pub-id-type="pmid">20451455</pub-id></element-citation></ref><ref id="b0045"><label>9</label><element-citation publication-type="journal" id="h0045"><person-group person-group-type="author"><name><surname>Hammarstedt</surname><given-names>L.</given-names></name><name><surname>Lindquist</surname><given-names>D.</given-names></name><name><surname>Dahlstrand</surname><given-names>H.</given-names></name></person-group><article-title>Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer</article-title><source>Int J Cancer</source><volume>119</volume><year>2006</year><fpage>2620</fpage><lpage>2623</lpage><pub-id pub-id-type="pmid">16991119</pub-id></element-citation></ref><ref id="b0050"><label>10</label><element-citation publication-type="journal" id="h0050"><person-group person-group-type="author"><name><surname>Venuti</surname><given-names>A.</given-names></name><name><surname>Paolini</surname><given-names>F.</given-names></name></person-group><article-title>HPV detection methods in head and neck cancer</article-title><source>Head Neck Pathol</source><volume>6</volume><issue>Suppl. 1</issue><year>2012</year><fpage>S63</fpage><lpage>S74</lpage><pub-id pub-id-type="pmid">22782225</pub-id></element-citation></ref><ref id="b0055"><label>11</label><element-citation publication-type="journal" id="h0055"><person-group person-group-type="author"><name><surname>El-Naggar</surname><given-names>A.K.</given-names></name><name><surname>Westra</surname><given-names>W.H.</given-names></name></person-group><article-title>P16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency</article-title><source>Head Neck</source><volume>34</volume><year>2012</year><fpage>459</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">22180304</pub-id></element-citation></ref><ref id="b0060"><label>12</label><element-citation publication-type="journal" id="h0060"><person-group person-group-type="author"><name><surname>Braakhuis</surname><given-names>B.J.</given-names></name><name><surname>Snijders</surname><given-names>P.J.</given-names></name><name><surname>Keune</surname><given-names>W.J.</given-names></name></person-group><article-title>Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus</article-title><source>J Natl Cancer Inst</source><volume>96</volume><year>2004</year><fpage>998</fpage><lpage>1006</lpage><pub-id pub-id-type="pmid">15240783</pub-id></element-citation></ref><ref id="b0065"><label>13</label><element-citation publication-type="journal" id="h0065"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>C.H.</given-names></name><name><surname>Gillison</surname><given-names>M.L.</given-names></name></person-group><article-title>Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications</article-title><source>Clin Cancer Res</source><volume>15</volume><year>2009</year><fpage>6758</fpage><lpage>6762</lpage><pub-id pub-id-type="pmid">19861444</pub-id></element-citation></ref><ref id="b0070"><label>14</label><element-citation publication-type="journal" id="h0070"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>E.M.</given-names></name><name><surname>Ritchie</surname><given-names>J.M.</given-names></name><name><surname>Summersgill</surname><given-names>K.F.</given-names></name></person-group><article-title>Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers</article-title><source>Int J Cancer</source><volume>108</volume><year>2004</year><fpage>766</fpage><lpage>772</lpage><pub-id pub-id-type="pmid">14696105</pub-id></element-citation></ref><ref id="b0075"><label>15</label><element-citation publication-type="journal" id="h0075"><person-group person-group-type="author"><name><surname>Gillison</surname><given-names>M.L.</given-names></name><name><surname>D&#x02019;Souza</surname><given-names>G.</given-names></name><name><surname>Westra</surname><given-names>W.</given-names></name></person-group><article-title>Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers</article-title><source>J Natl Cancer Inst</source><volume>100</volume><year>2008</year><fpage>407</fpage><lpage>420</lpage><pub-id pub-id-type="pmid">18334711</pub-id></element-citation></ref><ref id="b0080"><label>16</label><element-citation publication-type="journal" id="h0080"><person-group person-group-type="author"><name><surname>Worden</surname><given-names>F.P.</given-names></name><name><surname>Kumar</surname><given-names>B.</given-names></name><name><surname>Lee</surname><given-names>J.S.</given-names></name></person-group><article-title>Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number</article-title><source>J Clin Oncol</source><volume>26</volume><year>2008</year><fpage>3138</fpage><lpage>3146</lpage><pub-id pub-id-type="pmid">18474879</pub-id></element-citation></ref><ref id="b0085"><label>17</label><element-citation publication-type="journal" id="h0085"><person-group person-group-type="author"><name><surname>Lassen</surname><given-names>P.</given-names></name><name><surname>Eriksen</surname><given-names>J.G.</given-names></name><name><surname>Hamilton-Dutoit</surname><given-names>S.</given-names></name></person-group><article-title>Effect of HPV-associated p16(INK4A) expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck</article-title><source>J Clin Oncol</source><volume>27</volume><year>2009</year><fpage>1992</fpage><lpage>1998</lpage><pub-id pub-id-type="pmid">19289615</pub-id></element-citation></ref><ref id="b0090"><label>18</label><element-citation publication-type="journal" id="h0090"><person-group person-group-type="author"><name><surname>Fakhry</surname><given-names>C.</given-names></name><name><surname>Westra</surname><given-names>W.H.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name></person-group><article-title>Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial</article-title><source>J Natl Cancer Inst</source><volume>100</volume><year>2008</year><fpage>261</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">18270337</pub-id></element-citation></ref><ref id="b0095"><label>19</label><element-citation publication-type="journal" id="h0095"><person-group person-group-type="author"><name><surname>Licitra</surname><given-names>L.</given-names></name><name><surname>Perrone</surname><given-names>F.</given-names></name><name><surname>Bossi</surname><given-names>P.</given-names></name></person-group><article-title>High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma</article-title><source>J Clin Oncol</source><volume>24</volume><year>2006</year><fpage>5630</fpage><lpage>5636</lpage><pub-id pub-id-type="pmid">17179101</pub-id></element-citation></ref><ref id="b0100"><label>20</label><element-citation publication-type="journal" id="h0100"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>B.</given-names></name><name><surname>Cordell</surname><given-names>K.G.</given-names></name><name><surname>Lee</surname><given-names>J.S.</given-names></name></person-group><article-title>EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer</article-title><source>J Clin Oncol</source><volume>26</volume><year>2008</year><fpage>3128</fpage><lpage>3137</lpage><pub-id pub-id-type="pmid">18474878</pub-id></element-citation></ref><ref id="b0105"><label>21</label><element-citation publication-type="journal" id="h0105"><person-group person-group-type="author"><name><surname>Ang</surname><given-names>K.K.</given-names></name><name><surname>Harris</surname><given-names>J.</given-names></name><name><surname>Wheeler</surname><given-names>R.</given-names></name></person-group><article-title>Human papillomavirus and survival of patients with oropharyngeal cancer</article-title><source>N Engl J Med</source><volume>363</volume><year>2010</year><fpage>24</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">20530316</pub-id></element-citation></ref><ref id="b0110"><label>22</label><element-citation publication-type="journal" id="h0110"><person-group person-group-type="author"><name><surname>Kies</surname><given-names>M.S.</given-names></name><name><surname>Holsinger</surname><given-names>F.C.</given-names></name><name><surname>Lee</surname><given-names>J.J.</given-names></name></person-group><article-title>Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial</article-title><source>J Clin Oncol</source><volume>28</volume><year>2010</year><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">19917840</pub-id></element-citation></ref><ref id="b0115"><label>23</label><element-citation publication-type="journal" id="h0115"><person-group person-group-type="author"><name><surname>Rieckmann</surname><given-names>T.</given-names></name><name><surname>Tribius</surname><given-names>S.</given-names></name><name><surname>Grob</surname><given-names>T.J.</given-names></name></person-group><article-title>HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity</article-title><source>Radiother Oncol</source><year>2013</year><comment>[Epub ahead of print]</comment></element-citation></ref><ref id="b0120"><label>24</label><element-citation publication-type="journal" id="h0120"><person-group person-group-type="author"><name><surname>Gillison</surname><given-names>M.L.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Jordan</surname><given-names>R.</given-names></name></person-group><article-title>Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer</article-title><source>J Clin Oncol</source><volume>30</volume><year>2012</year><fpage>2102</fpage><lpage>2111</lpage><pub-id pub-id-type="pmid">22565003</pub-id></element-citation></ref><ref id="b0125"><label>25</label><element-citation publication-type="journal" id="h0125"><person-group person-group-type="author"><name><surname>O&#x02019;Sullivan</surname><given-names>B.</given-names></name><name><surname>Huang</surname><given-names>S.H.</given-names></name><name><surname>Siu</surname><given-names>L.L.</given-names></name></person-group><article-title>Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis</article-title><source>J Clin Oncol</source><volume>31</volume><year>2013</year><fpage>543</fpage><lpage>550</lpage><pub-id pub-id-type="pmid">23295795</pub-id></element-citation></ref></ref-list></back></article>